A potent in vivo anti-tumor efficacy of novel recombinant type I interferon

par Zhang, Kang-Jian, Yin, Xiao-Fei, Yang, Yuan-Qin, Li, Hui-Ling, Xu, Yan-Ni, Chen, Lie-Yang, Liu, Xi-Jun, Yuan, Su-Jing, Fang, Xian-Long, Xiao, Jing, Wu, Shuai, Xu, Hai-Neng, Chu, Liang, Katlinski, Kanstantsin V., Katlinskaya, Yuliya V., Guo, Rong-Bing, Wei, Guang-Wen, Wang, Da-Cheng, Liu, Xin-Yuan, Fuchs, Serge Y.
Publié dans Clin Cancer Res (2016)